The pathology of epithelial pre-malignancy of the gastrointestinal tract

Best Practice and Research: Clinical Gastroenterology

Volumn 15, Issue 2, 2001, Pages 191-210

  Guindi, Maha ^a   Riddell, Robert H ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Adenoma; Barrett's oesophagus; Crohn's disease; DALM; Gastric dysplasia; High grade dysplasia; Inflammatory bowel disease; Interobserver variation; Intra epithelial neoplasia; Low grade dysplasia; Squamous dysplasia; Surveillance; Ulcerative colitis

Indexed keywords

ARTICLE; BARRETT ESOPHAGUS; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GRADING; CANCER RISK; COLON ADENOMA; COLON BIOPSY; COLON MUCOSA; COLUMNAR EPITHELIUM; ENTERITIS; EPITHELIUM DYSPLASIA; EPITHELIUM TUMOR; ESOPHAGOSCOPY; ESOPHAGUS CANCER; ESOPHAGUS CARCINOMA; ESOPHAGUS MUCOSA; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL MUCOSA; GASTROINTESTINAL TRACT; GASTROINTESTINAL TUMOR; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE MUCOSA; OBSERVER VARIATION; PATHOLOGIST; PATHOLOGY; PRECANCER; PREDICTION; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; STOMACH EPITHELIUM; STOMACH MUCOSA;

EID: 0034966853     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.2001.0169     Document Type: Article

References (108)

1. Pre-malignant and early malignant lesions of the gastrointestinal tract: Definitions, terminology and problems
2. Juvenile polyposis - A precancerous condition
3. Familial juvenile polyposis coli: Increased risk of colorectal cancer
4. Peutz-Jeghers syndrome: Risks of a hereditary condition
5. Neoplastic transformation arising in Peutz-Jeghers polyposis
6. Histological classification of intraepithelial neoplasias and microinvasive squamous carcinoma of the oesophagus
7. Intraepithelial carcinoma concomitant with oesophageal carcinoma
8. Biological characteristics of oesophageal squamous cell carcinoma associated with contiguous intraepithelial carcinoma
9. Serial histologic evaluation of multiple primary squamous cell carcinomas of the oesophagus
10. Extensive spreading carcinoma of the oesophagus with invasion restricted to the submucosa
11. Squamous dysplasia and early oesophageal cancer in the Linxian region of China: Distinctive endoscopic lesions
12. Squamous oesophageal histology and subsequent risk of squamous cell carcinoma of the oesophagus. A prospective follow-up study from Linxian, China
13. Oesophageal morphology from Linxian, China. Squamous histologic findings in 754 patients
14. Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the oesophagus in Linxian, China
15. Oesophagitis in a population at risk for oesophageal carcinoma
16. A case-control study of cancer of the oesophagus and gastric cardia in Linxian
17. Precursor lesions of esophageal cancer in high risk populations in Henan province, China
18. Barrett's mucosa in conjunction with squamous carcinoma of the oesophagus
19. Differences in diagnostic criteria for oesophageal squamous cell carcinoma between Japanese and Western pathologists
20. The incidence of adenocarcinoma in Barrett's oesophagus: A prospective study of 170 patients followed 4.8 years
21. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's oesophagus
22. Dysplasia in Barrett's oesophagus
23. Endoscopic surveillance for patients with Barrett's oesophagus: Does the cancer risk justify the practice?
24. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's oesophagus with high-grade dysplasia
25. Barrett's oesophagus: Development of dysplasia and adenocarcinoma
26. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's oesophagus
27. Dysplasia in Barrett's oesophagus. A clinicopathologic study of six patients
28. Management of dysplasia in the columnar-lined oesophagus
29. Superficial adenocarcinoma of the oesophagus
30. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's oesophagus without grossly recognizable neoplastic lesions
31. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma
32. A human model of gastric carcinogenesis
33. Human gastric carcinogenesis: A multistep and multifactorial process
34. A genetic model for colorectal tumorigenesis
35. The two main histological types of gastric carcinoma: Diffuse and so-called intestinal type. An attempt at a histo-clinical classification
36. Dysplasia of nonmetaplastic gastric mucosa. A proposal for its classification and its possible relationship to diffuse-type gastric carcinoma
37. A classification of gastric dysplasia
38. Gastric dysplasia. Significance and pathologic criteria
39. Precancerous conditions and epithelial dysplasia in the stomach
40. Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists
41. Problems arising from eastern and western classification systems for gastrointestinal dysplasia and carcinoma: Are they resolvable?
42. Evaluation of gastric biopsies for neoplasia: Differences between Japanese and Western pathologists
43. East meets West: What is early cancer?
44. Gastric dysplasia: The Padova international classification
45. Gastritis and gastric neoplasia
46. Intestinal metaplasia types and the risk of gastric cancer: A cohort study in Slovenia
47. The Vienna classification of gastrointestinal epithelial neoplasia
48. Histogenesis of human gastric cancer: With special reference to the significance of adenoma as a precancerous lesion
49. Long-term follow-up study on gastric adenoma and its relation to gastric protruded carcinoma
50. Histologic types and surveillance of gastric polyps: A seven year clinico-pathological study
51. Gastric polyps; their morphological and endoscopical characteristics and relation to gastric carcinoma
52. Malignant potential of epithelial polyps of the stomach
53. Histopathological classification and malignant change in gastric polyps
54. Association between histologic type of polyp and carcinoma in the stomach
55. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection Prospective randomized intervention study
56. Impact of Helicobacter pylori eradication on the development of MALT, gland atrophy and intestinal metaplasia of the antrum
57. Follow-up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori
58. Helicobacter pylori eradication and antral intestinal metaplasia - Two years follow-up study
59. Two-to four-year histological follow-up of gastric mucosa after Helicobacter pylori eradication
60. Reversal of fundic atrophy after eradication of Helicobacter pylori
61. Malignant transformation of gastric hyperplastic polyps
62. The histopathology of fundic gland polyps of the stomach
63. Fundic gland polyps: Prevalence and clinicopathologic features
64. Fundic gland polyposis in patients without familial adenomatosis coli: Its incidence and clinical features
65. A clinical and histopathological study of gastric polyps in familial polyposis coli
66. Gastric fundic gland polyps: A morphological study including mucin histochemistry, stereometry, and MIB-I immunohistochemistry
67. Gastric carcinoma and familial adenomatous polyposis (FAP)
68. Upper gastrointestinal pathology in familial adenomatous polyposis: Results from a prospective study of 102 patients
69. Gastric adenocarcinoma complicating Gardner's syndrome in a North American woman
70. Advanced gastroduodenal polyposis with ras mutations in a patient with familial adenomatous polyposis
71. Gastric adenocarcinoma and dysplasia in fundic gland polyps of a patient with attenuated adenomatous polyposis coli
72. Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications
73. Inflammatory bowel disease
74. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?
75. Can histopathologists reliably assess dysplasia in chronic inflammatory bowel disease?
76. Observer reproducibility in grading dysplasia in colorectal adenomas: Comparison between two different grading systems
77. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis
78. Observer study of the grading of dysplasia in ulcerative colitis: Comparison with clinical outcome
79. Observer variation in the assessment of dysplasia in ulcerative colitis
80. Observer variation in the diagnosis of dysplasia in Barrett's oesophagus
81. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: Implications for carcinogenesis and prevention
82. Cancer surveillance in ulcerative colitis - A time for reappraisal
83. Neoplastic progression in ulcerative colitis: Histology, DNA content, and loss of a p53 allele
84. Precancer and cancer in extensive ulcerative colitis: Findings among 401 patients over 22 years
85. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: An indication for colectomy
86. Macroscopic lesions in dysplasia and carcinoma complicating ulcerative colitis
87. Surveillance for colonic carcinoma in ulcerative colitis
88. Villous dysplasia. An ominous histologic sign in colitic patients
89. Polypoid dysplasia and adenomas in inflammatory bowel disease: A clinical, pathologic, and follow-up study of 89 polyps from 59 patients
90. Comparison of genetic alterations in colonic adenoma and ulcerative colitis-associated dysplasia and carcinoma
91. Loss of heterozygosity of the von Hippel Lindau gene locus in polypoid dysplasia but not flat dysplasia in ulcerative colitis or sporadic adenomas
92. p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma
93. The differentiation of true adenomas from colitis-associated dysplasia in ulcerative colitis: A comparative immunohistochemical study
94. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis
95. ALMs versus DALMs in ulcerative colitis: Polypectomy or colectomy?
96. Inhibition of human colonic epithelial cell proliferation in vivo and in vitro by calcium
97. Expansion of the epithelial cell proliferative compartment and frequency of adenomatous polyps in the colon correlate with the strength of family history of colorectal cancer
98. Inherited colon cancer: Clinical implications
99. Risk of colorectal cancer in adenoma-bearing individuals within a defined population
100. Pre-malignancy of the mucosal polyp in the large intestine. II. Estimation of the periods required for malignant transformation of mucosal polyps
101. Histological typing of intestinal tumours
102. Dysplasia in the large intestine
103. Small 'flat adenoma' of the large bowel with special reference to its clinicopathologic features
104. Diminutive colonic polyps - Clinical significance and management
105. Epidemiology of polyps in the rectum and colon. Recovery and evaluation of unresected polyps 2 years after detection
106. Use of colonoscopy to screen asymptomatic adults for colorectal cancer